About

Signed an exclusive Korean agency agreement with Biocytogen in China Launched CRO service for humanized mice

Signed an MOU with KMEDI hub Conducted joint research on cell therapy and pharmaceutical products for pets

Signed an MOU with Biotoxtech Collaborated on non-clinical business project using humanized mice

Signed an MOU with the Efficacy Evaluation Center of Jeonbuk National University Hospital Communicated and collaborated on non-clinical efficacy evaluation and business project

-Completed new animal rooms and experiment facilities
-Signed an exclusive Korean agency agreement with Bioworkshops in China
-Launched antibody drug CDMO service.

Selected as a IBK Changgong Innovative Startup for 2H 2023

-Signed an MOU for the research and development of domestic and international pet businesses (Company N)
-ISO 9001:2015 and ISO 14001:2015 certified

Registered trademark for (CertiCell).

Certified as an Excellent Technology Enterprise (for developing therapeutic treatments using pet stem cells)

Certified as a venture company
Relocated to Paltan-myeon, Hwaseong-si, Gyeonggi-do

Contracted to develop anti-cancer and osteoporosis drugs for dogs (Company S)

Completed technology transfer for PCR-based diagnostic technology for major pathogens in pets (N Company)

Filed a patent application (for a composition to measure mesenchymal stem cell activity and a kit using this composition)

Selected as a contactless service voucher business partner by the Ministry of SMEs and Startups

-Certified as a Class 2 LMO facility
-Selected for the early-stage startup package by Korea University's Crimson Startup
-Support Group Awarded with special employment promotion incentives from the Ministry of Employment and Labor

Certified as a small and medium-sized enterprise Certified
Certified as a corporate research lab

Established Cellpurix Inc. (in Seongsu-dong, Seongdong-gu, Seoul)